Urine collagen fragments and CKD progression- the cardiovascular health study

Journal of the American Society of Nephrology

Volumn 26, Issue 10, 2015, Pages 2494-2503

  Ix, Joachim H ^a   Biggs, Mary L ^b   Mukamal, Kenneth ^c   Djousse, Luc ^d   Siscovick, David ^e   Tracy, Russell ^f   Katz, Ronit ^g   Delaney, Joseph A ^b   Chaves, Paulo ^h   Rifkin, Dena E ^a   Hughes Austin, Jan M ^a   Garimella, Pranav S ⁱ   Sarnak, Mark J ⁱ   Shlipak, Michael G ^j   Kizer, Jorge R ^k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h FLORIDA INTERNATIONAL UNIVERSITY   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; SIGNAL TRANSDUCTION; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; HEART FAILURE; URINE;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84942858199     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014070696     Document Type: Article

References (38)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van-Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007.
2. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determiningriskbasedonkidney function.N Engl J Med 369:932-943, 2013.
3. KDIGO: 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1-150, 2013.
4. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD: The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152: 561-567, 2010.
5. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. AmJ Kidney Dis 20: 1-17, 1992.
6. Howie AJ, Ferreira MA, Adu D: Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 16: 1163-1169, 2001.
7. Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N: Benign nephrosclerosis: Incidence, morphology and prognosis. Clin Nephrol 55: 349-356, 2001.
8. Ghoul BE, Squalli T, Servais A, Elie C, Meas-Yedid V, Trivint C, Vanmassenhove J, Grünfeld JP, Olivo-Marin JC, Thervet E, Noël LH, Prié D, Fakhouri F: Urinary procollagen III aminoterminal propeptide (PIIINP): A fibrotest for the nephrologist. Clin J AmSoc Nephrol 5: 205- 210, 2010.
9. Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C: Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients. Transplantation 75: 2113-2119, 2003.
10. Soylemezoglu O, Wild G, Dalley AJ, MacNeil S, Milford-Ward A, Brown CB, el-Nahas AM: Urinary and serum type III collagen: Markers of renal fibrosis. Nephrol Dial Transplant 12: 1883-1889, 1997.
11. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049- 2060, 2005.
12. Kassirer JP: Clinical evaluation of kidney function-glomerular function. N Engl J Med 285: 385-389, 1971.
13. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study: Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142: 497-505, 2005.
14. Dominguez JR, Kestenbaum B, Chonchol M, Block G, Laughlin GA, Lewis CE, Katz R, Barrett-Connor E, Cummings S, Orwoll ES, Ix JH; Osteoporotic Fractures in Men (MrOS) Study Research Group: Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: The Osteoporotic Fractures in Men (MrOS) Study. Am J Kidney Dis 61: 555-563, 2013.
15. Driver TH, Shlipak MG, Katz R, Goldenstein L, Sarnak M, Hoofnagle A, Siscovick D, Kestenbaum B, De Boer IH, Ix JH: Low serum bicarbonate as a predictor of rapid kidney function decline and incident chronic kidney disease: The Multi-Ethnic Study of Atherosclerosis. (MESA). Am J Kidney Dis 64:534-541, 2014.
16. Goldenstein L, Driver TH, Fried LF, Rifkin DE, Patel KV, Yenchek RH, Harris TB, Kritchevsky SB, Newman AB, Sarnak MJ, Shlipak MG, Ix JH; Health ABC Study Investigators: Serum bicarbonate concentrations and kidney disease progression in community-living elders: TheHealth, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 64: 542-549, 2014.
17. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S: Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int 79: 356- 362, 2011.
18. Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG: Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 60: 904-911, 2012.
19. Bhavsar NA, Köttgen A, Coresh J, Astor BC: Neutrophil gelatinaseassociated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 60: 233-240, 2012.
20. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L: Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 34: 715-718, 1988.
21. Bentsen KD, Henriksen JH, Bendtsen F, Hørslev-Petersen K, Lorenzen I: Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology 11: 957-963, 1990.
22. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991.
23. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3: 358-366, 1993.
24. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, CirilloM, Djurdjev O, Green JA, HeineGH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de-Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518-2531, 2014.
25. Sakkinen PA, Macy EM, Callas PW, Cornell ES, Hayes TE, Kuller LH, Tracy RP: Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: Assessment and implications for epidemiology. Am J Epidemiol 149: 261-267, 1999.
26. Agarwal I, Glazer NL, Barasch E, Biggs ML, Djoussé L, Fitzpatrick AL, Gottdiener JS, Ix JH, Kizer JR, RimmEB, Siscovick DS, Tracy RP, Zieman SJ, Mukamal KJ: Fibrosis-related biomarkers and risk of total and causespecific mortality: The cardiovascular health study. Am J Epidemiol 179: 1331-1339, 2014.
27. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van-Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serumcreatinine: Apooled analysis of 3, 418 individualswithCKD. Am J Kidney Dis 51: 395-406, 2008.
28. Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L: Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26: 379-385, 2011.
29. Gottdiener JS, Arnold AM, AurigemmaGP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC: Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J AmColl Cardiol 35: 1628-1637, 2000.
30. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5: 278-285, 1995.
31. Price TR, Psaty B, O'Leary D, Burke G, Gardin J: Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol 3: 504-507, 1993.
32. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5: 270-277, 1995.
33. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP: C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The cardiovascular health study. Circulation 112: 25-31, 2005.
34. Ix JH, de-Boer IH, Wassel CL, Criqui MH, Shlipak MG, Whooley MA: Urinary creatinine excretion rate andmortality in persons with coronary artery disease: The Heart and Soul Study. Circulation 121: 1295-1303, 2010.
35. Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS: Equations to estimate creatinine excretion rate: The CKD epidemiology collaboration. Clin J Am Soc Nephrol 6: 184-191, 2011.
36. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van-Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009.
37. Barlow WE, Ichikawa L, Rosner D, Izumi S: Analysis of case-cohort designs. J Clin Epidemiol 52: 1165-1172, 1999.
38. Therneau TM, Li H: Computing the Cox model for case cohort designs. Lifetime Data Anal 5: 99-112, 1999.